Pharmaceutical firms continue to invest in research into the healing potential of cannabinoids, launching clinical trials to investigate their ability to treat a range of conditions
Written by Lorraine Mullaney || 11th December 2020 || News analysis | Health and science | Europe North America United Kingdom United States